SCHEMBL31110180

SCHEMBL31110180

COc1ccc(NC(=O)c2cccc(NCCCCCCCN)c2C)nn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 3/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ ROCK2 O75116 2/20 0.38
▸ ROCK1 Q13464 2/20 0.38
▸ HDAC1 Q13547 3/20 0.38
▸ HDAC3 O15379 2/20 0.38
▸ MAPK1 P28482 2/20 0.36
▸ RXFP1 Q9HBX9 2/20 0.36
▸ GPR52 Q9Y2T5 1/20 0.35
▸ RAD52 P43351 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ HSP90AB1 P08238 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31110137 0.89 SORT1 (0.41) F10ALDH1A1KMT2AMEN1TP53
SCHEMBL31665042 0.86 KDM4E (0.36) ALDH1A1KMT2AMEN1HDAC1HDAC3
SCHEMBL25142787 0.81 NPC1 (0.53) F10ALDH1A1KMT2ATP53RXFP1
SCHEMBL31110115 0.81 NPC1 (0.53) F10ALDH1A1KMT2ATP53RXFP1
SCHEMBL25142789 0.78 HDAC3 (0.40) F10ALDH1A1KMT2AMEN1TP53
SCHEMBL31110092 0.78 ALDH1A1 (0.44) F10ALDH1A1KMT2AMEN1TP53
SCHEMBL11935789 0.77 ROCK1 (0.45) ALDH1A1KMT2AMEN1TP53HTT
SCHEMBL31110135 0.77 RXFP1 (0.44) ALDH1A1KMT2AMEN1TP53HDAC1
SCHEMBL25142910 0.75 PIK3CA (0.47) ALDH1A1HDAC1HDAC3NPC1KDM4E
SCHEMBL31110240 0.75 PIK3CA (0.47) ALDH1A1HDAC1HDAC3NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2025-07-24 — — US disclosed
CN-118451078-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2024-08-06 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, TP53BP1 F10 3120/4885ALDH1A1 2239/4885KMT2A 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback